Supriya Lifescience Limited

📍 Mumbai, Maharashtra, India Active NSE SUPRIYA CIN L51900MH2008PLC180452 Pharmaceuticals & Healthcare

Search companies

Key Metrics of Supriya Lifescience Limited

Revenue₹828 Cr▲ 18.9% YoYFY 2025-26

EBITDA₹305 Cr▲ 12.7% YoY

Net profit₹209 Cr▲ 11.3% YoY

Net worth₹1,198 Cr▲ 20.2% YoY

Competitors10identified

About Supriya Lifescience Limited

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Registered office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (east), Mumbai, In-mh, 400063
Listed: NSE: SUPRIYA · ₹833.05

Operational Areas of Supriya Lifescience Limited

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Entity details

CINL51900MH2008PLC180452

LEI code894500RBVJX1EOJP0Y02

State codeMH

PIN code400063

Current legal nameSUPRIYA LIFESCIENCE LIMITED

Classification—

Listing statusListed (NSE: SUPRIYA)

Registration no.180452

Company age—

PAN—

CountryIndia

CityMumbai

StateMaharashtra

Current statusActive

Date of incorporation—

Registrar of companies—

Authorised capital—

Paid-up capital—

Employee count—

Compliance

Last AGM date—

Last balance sheet—

Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code51900

Description of main activityWholesale trade and commission trade

Description of business activityWholesale trade and commission trade

SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed

AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 4 days left

MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 34 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—

Indicative short-term—

Score—

LiquidityAdequate

DirectionStable

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

Default	No default on record
Issuer cooperation	Cooperating
Credit enhancement	None – standalone rating
Information on file	56% · missing: Capex / investment plans, Lender details, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Registered office and contact

Registered office207/208, UDYOG BHAVAN, SONAWALA ROAD, GOREGAON (EAST), MUMBAI, IN-MH, 400063

GSTIN—

Email—

Website—

Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Supriya Lifescience Limited

Competitors10identified

Locations2most in India

Top competitors by location

Company	Description	Domain	Founded	Location
Dr. Reddy's Laboratories	Part of Dr. Reddy's Laboratories.	drreddys.com	1984	India
Aurobindo Pharma	Part of Aurobindo Pharma.	aurobindo.com	1986	Hyderabad, India
Cipla	Part of Cipla.	cipla.com	1935	Mumbai, India
Lupin Ltd.	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	lupin.com	1968	India
Glenmark Pharmaceuticals	Part of Glenmark Pharmaceuticals.	glenmarkpharma.com	1977	Mumbai, India
Biocon	Part of Biocon.	biocon.com	1978	Bangalore, India
ALKEM LABORATORIES LIMITED	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	alkemlabs.com	1973	Mumbai, Maharashtra, India
Torrent Pharmaceuticals	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	torrentpharma.com	1959	Ahmedabad, India
Thomas Cook India	Part of Thomas Cook Group.	thomascook.in	1978	Mumbai, India
Divi's Laboratories	Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare	divislabs.com	1990	Hyderabad, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.